Japan Sexually-Transmitted Diseases (STD), 2019-2023: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

About This Report3

This report presents a detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies;

-  Reviews features and operating characteristics of major analyzers used
   for STD testing;

-  Profiles key suppliers and potential market entrants developing innovative
   Technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies,
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the proprietary data files was conducted.



I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VI. Japan: Market Size, Growth and Major Suppliers
Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

List Of Tables


Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
Japan
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Diagnostics Sales by Major Supplier
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment

Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Herpes Testing Market Diagnostics Sales
by Major Supplier
Japan
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Testing Market Diagnostics Sales
by Major Supplier

2024 Japan In Vitro Diagnostics Market for 500 Tests: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Business Environment, Market Structure, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report provides an overview of the Japanese diagnostic testing market.The report is available by section, and can be customized to specific information needs and budget.The report includes sales

USD 4500 View Report

2024 Japan Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report contains 887 pages and 72 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of

USD 3500 View Report

2019-2024 Japan Sexually-Transmitted Disease (STD) Market Shares and Segment Forecasts: Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis

About This ReportThis new 280-page report presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 2450 View Report

U.S. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023

About This ReportThis new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 2450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available